Moderna Inc.

NASDAQ: MRNA · Real-Time Price · USD
28.00
1.31 (4.91%)
At close: Aug 15, 2025, 3:59 PM
28.04
0.12%
After-hours: Aug 15, 2025, 07:58 PM EDT

Moderna Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.2B 6.85B 18.88B 17.74B
Cost of Revenue
1.46B 4.69B 5.42B 2.62B
Gross Profit
1.74B 2.15B 13.46B 15.12B
Operating Income
-3.94B -4.24B 9.42B 13.3B
Interest Income
425M 421M 200M 18M
Pretax Income
-3.61B -3.94B 9.57B 13.29B
Net Income
-3.56B -4.71B 8.36B 12.2B
Selling & General & Admin
1.17B 1.55B 1.13B 567M
Research & Development
4.54B 4.84B 3.29B 1.99B
Other Expenses
-37M n/a -388M -735M
Operating Expenses
5.68B 6.39B 4.04B 1.82B
Interest Expense
24M 38M 29M 18M
Selling & Marketing Expenses
n/a 204M 121M n/a
Cost & Expenses
7.14B 11.09B 9.46B 4.44B
Income Tax Expense
-46M 772M 1.21B 1.08B
Shares Outstanding (Basic)
384M 382M 394M 403M
Shares Outstanding (Diluted)
384M 382M 416M 431M
EPS (Basic)
-9.27 -12.34 21.26 30.31
EPS (Diluted)
-9.27 -12.34 20.10 28.29
EBITDA
-3.39B -3.28B 9.77B 13.53B
EBIT
-3.58B -3.9B 9.42B 13.3B
Depreciation & Amortization
189M 621M 348M 232M